intestinal disease
Information
- Disease name
- intestinal disease
- Disease ID
- DOID:5295
- Description
- "A gastrointestinal system disease that is located_in the intestine." [url:http\://en.wikipedia.org/wiki/Human_gastrointestinal_tract]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05551052 | Active, not recruiting | CRC Detection Reliable Assessment With Blood | September 8, 2022 | July 2024 | |
| NCT01787825 | Completed | N/A | Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease | May 2012 | February 2016 |
| NCT02569333 | Completed | N/A | Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis | January 2016 | January 2020 |
| NCT02785783 | Completed | N/A | Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection | May 13, 2016 | August 7, 2018 |
| NCT03012594 | Completed | Phase 2 | Lanreotide in the Treatment of Small Bowel Motility Disorders | May 11, 2017 | March 11, 2019 |
| NCT03037385 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | March 17, 2017 | March 21, 2024 |
| NCT06295575 | Completed | N/A | Effect of Probiotics on Patients With Congenital Heart Disease Following Cardiopulmonary Bypass | June 1, 2021 | July 1, 2022 |
| NCT03463304 | Completed | Environmental Factors and the Gut Microbiome - Endocannabinoid Axis | February 13, 2018 | December 30, 2018 | |
| NCT03509220 | Completed | Phase 3 | Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy | April 11, 2018 | October 31, 2018 |
| NCT03543540 | Completed | Phase 1 | Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease | May 1, 2018 | September 10, 2018 |
| NCT03559543 | Completed | Phase 2 | Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma | October 25, 2018 | January 15, 2024 |
| NCT03723447 | Completed | Phase 4 | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) | October 23, 2018 | October 29, 2019 |
| NCT03817645 | Completed | N/A | Panaceo "MED" for IBS (Irritable Bowel Syndrome) | March 9, 2018 | June 30, 2020 |
| NCT04263818 | Completed | N/A | Endoscopist and Endoscope Motions During Colonoscopy | June 5, 2020 | July 5, 2021 |
| NCT04573959 | Completed | N/A | Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System | October 1, 2015 | June 11, 2020 |
| NCT04982302 | Completed | Gut Microbial Changes After Periodontal Treatment | May 1, 2021 | February 1, 2023 | |
| NCT05234515 | Completed | Bacteriology of sUrGical Site INfection Following Surgery for Intestinal Failure | January 14, 2022 | February 20, 2023 | |
| NCT00072943 | Completed | Phase 2 | A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease | March 2002 | April 2004 |
| NCT06178302 | Not yet recruiting | DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne grouP Practice | January 2024 | June 2035 | |
| NCT06271538 | Not yet recruiting | Phase 4 | Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome | May 31, 2024 | March 30, 2025 |
| NCT06112353 | Not yet recruiting | Phase 4 | Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection | April 2024 | December 2024 |
| NCT06026449 | Recruiting | N/A | Gluten-free Diet in PSC and IBD | January 1, 2023 | August 30, 2026 |
| NCT04755920 | Recruiting | Phase 2 | SGM-101 in Colorectal Brain Metastases. | January 1, 2024 | February 2026 |
| NCT05194527 | Recruiting | The Detrimental Course of Acute Intestinal Ischemia | September 15, 2020 | September 15, 2024 | |
| NCT03280407 | Recruiting | Phase 2 | NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer | March 1, 2017 | December 31, 2024 |
| NCT05209568 | Recruiting | N/A | Immune Responses to Gluten | January 15, 2023 | September 30, 2029 |
| NCT05923918 | Recruiting | Phase 3 | A Study to Evaluate Safety and Efficacy of PBK_M2101 | June 2023 | June 2024 |
| NCT06007313 | Recruiting | Mental Stress and Bowel Preparation Quality | May 1, 2023 | August 30, 2023 | |
| NCT03462979 | Suspended | N/A | Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease | April 15, 2018 | December 31, 2023 |
| NCT04123990 | Unknown status | N/A | Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease | November 2, 2019 | March 30, 2020 |
| NCT04502784 | Unknown status | Investigation of Hypophosphataemia Following Intravenous Iron | October 7, 2019 | December 31, 2020 | |
| NCT04662853 | Unknown status | Gut Microbiota and Color-rectal Cancer. | January 17, 2017 | July 31, 2021 | |
| NCT05249335 | Unknown status | Phase 4 | Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly | February 2022 | February 2024 |
| NCT04605627 | Unknown status | The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease. | October 8, 2020 | December 31, 2023 | |
| NCT01236833 | Unknown status | Phase 2 | Lactated Ringer's Solution in Neonates With Feeding Intolerance | November 2010 | September 2012 |
| NCT03267355 | Unknown status | N/A | Indications and Outcomes of Endoscopic Ultrasound in Tanta | January 2016 | December 2019 |
| NCT03644069 | Unknown status | Phase 2 | A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) | August 6, 2018 | September 2019 |
- Disase is a (Disease Ontology)
- DOID:77
- Cross Reference ID (Disease Ontology)
- ICD10CM:K63.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:569.9
- Cross Reference ID (Disease Ontology)
- MESH:D007410
- Cross Reference ID (Disease Ontology)
- NCI:C26801
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266483008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0021831